Singapore: Swiss firm Biosafe, an automated cell processing system manufacturer, has strengthend its presence in China in cord blood banking, regenerative medicine and bioprocessing markets with manpower and facility expansion.

Olivier Waridel, CEO, Biosafe said, "The expansion of our China operations underlines the commitment of Biosafe to cooperate with the Chinese cell therapy community, by working more closely with our clients and scientific partners in China. Biosafe looks forward to further developing close relationships with them and is enthusiastic about jointly supporting their efforts".